CBS 11 Header TXA 21 Header MeTV Header KRLD Header The Fan Header
CBS DFW WEATHER APP: iPhone App Store | Android App Coming Soon | More Information

News

FDA Approves Drug For Most Common Skin Cancer

View Comments

CBS DFW (con't)

Affordable Care Act Updates: CBSDFW.com/ACA

Health News & Information: CBSDFW.com/Health

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

From Our CBS Music Web Sites

625x352 thrill eng preview FDA Approves Drug For Most Common Skin CancerWin A Trip To Disneyland!

82641739 10 FDA Approves Drug For Most Common Skin CancerHottest Sunbathers Of The Summer

451506504 FDA Approves Drug For Most Common Skin CancerJennifer Lopez Bikini Pic Is HOT

 alt=What Did Jerry Jones Say?

 alt=Musicians Then And Now

Fantasy_tile

VOTE: Best Coaches In American Sports

erivedge FDA Approves Drug For Most Common Skin Cancer

The drug Erivedge, shown here in its packaging, was approved by the FDA to help treat common forms of skin cancer. (credit: Genentech)

NEW YORK (CBS) - The FDA has approved a new drug called Erivedge to treat basal cell carcinoma, the most common form of skin cancer. Federal regulators announced Monday the approval of the Erivedge pill, the first drug ever approved for treating basal cell carcinoma. Typical BCC treatments include outpatient procedures such as freezing or surgically removing the cancerous area. The pill is made by Genentech, a unit of Swiss drugmaker Roche. Erivedge is a once-per-day capsule that’s intended to treat locally advanced cancer for patients who are not candidates for surgery or radiation, and for patients whose cancer has spread to other parts of the body.

Click Here For More Info From CBS News

Also Check Out:

View Comments